Carroucell Raises €1.5 Million To Introduce Breakthrough Microcarriers And Customizable Processes To Cell And Gene Therapy Market

Sep 07, 2022•over 3 years ago

Amount Raised

€1.5 Million

Round Type

seed

GrenobleBiotechnologyManufacturing

Description

Carroucell, the microcarrier supplier for cell culture in bioreactor, announced today that it has raised a total of €1.5 million. The funding includes the closing of a Series A financing, led by the Novalis Biotech Acceleration fund and with participation of Crédit Agricole des Savoie (CADS), as well as support from Bpifrance. The funding will be used to accelerate corporate growth through industrialization of the company’s platform technology and ramping up of mass production processes to GMP standards.

Company Information

Company

Carroucell

Location

Grenoble, Auvergne Rhône Alpes, France

About

Carroucell is a biotech company who provides innovative solutions continuously into the bioproduction market more specifically the biomanufacturing field in creating the next generation of microcarrier technologies. Carroucell solutions solve enormous current challenges and issues regarding the performance of the biomanufacturing. Our ambition and mission are to impact positively the bioproduction performance through our disruptive microcarriers in addition to our agile approach to create a new future for all patients who can get a better access to the therapeutic innovations.

Related People

3 contacts

Carroucell Raises €1.5 Million To Introduce Breakthrough Microcarriers And Customizable Processes To Cell And Gene Therapy Market

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Company Information